Shimose, S., Iwamoto, H., Niizeki, T., Shirono, T., Noda, Y., Kamachi, N., . . . Torimura, T. (2020). Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Cancers (Basel).
استشهاد بنمط شيكاغوShimose, Shigeo, et al. "Clinical Significance of Adverse Events for Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study." Cancers (Basel) 2020.
MLA استشهادShimose, Shigeo, et al. "Clinical Significance of Adverse Events for Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study." Cancers (Basel) 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.